# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Jordan Levy reiterates Aemetis (NASDAQ:AMTX) with a Hold and raises the price target from $3.5 to $4.
HC Wainwright & Co. analyst Amit Dayal reiterates Aemetis (NASDAQ:AMTX) with a Buy and maintains $28 price target.
Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity p...
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...
HC Wainwright & Co. analyst Amit Dayal reiterates Aemetis (NASDAQ:AMTX) with a Buy and maintains $28 price target.
Aemetis (NASDAQ:AMTX) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.34) by ...
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...